- CT Business News Journal

Achillion Raises $41.8M Through Stock Offering

E-mail Print PDF
NEW HAVEN — Achillion Pharmaceuticals Inc. has entered into a definitive agreement with funds managed by generic tramadol Financial LP for the sale of 6,367,853 shares of its common stock.

The investors have agreed to purchase the shares of common stock at a price of $6.57 per share, resulting in buy valium online proceeds to Achillion of approximately $41.8 million. The sale was expected to close on generic valium about September 4, subject to closing conditions.

The securities described above are being offered directly to the purchasers by Achillion pursuant to a registration statement previously filed with and subsequently declared effective by the Securities & Exchange Commission.

Achillion is a pharmaceutical developer focused on new treatments for patients with infectious disease, including HCV and resistant bacterial infections.


Tech Stocks

Powered by Stock Trader